Abstract

BackgroundOncolytic viral immunotherapy utilizes viruses that preferentially infect and replicate within cancer cells, resulting in both tumor cell destruction and activation of an anti-tumor immune response. However, a major obstacle...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call